According to CNNMoney.com, the popular over-the-counter weight loss drug, Alli, is being recalled in the US and Puerto Rico due to possible tampering. GlaxoSmithKline, the British company that manufactures Alli, said the recall comes after complaints from customers in seven US states.
“A range of tablets and capsules of various shapes and colors were reported to be found inside bottles,” the company said in a statement. “Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.”
A spokesperson for GlaxoSmithKline said the questionable Alli was purchased in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas. The company described Alli as a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat”, which is the active compound that prevents the absorption of fat.
GlaxoSmithKline said they are conducting an investigation with the Food and Drug Administration (FDA) to determine the cause of the drug tampering.
Did a Dangerous Drug Hurt You? Let Our Austin Injury Attorney Help
This is a scary situation for consumers. The public has the reasonable expectation that all products for sale are generally safe and that they will not cause harm when properly used. When a product is dangerous because it was defectively manufactured, or it did not provide adequate warnings about potential hazards, serious personal injuries often occur.
If you have been injured by a dangerous or defective product, The Law Offices of Aaron Allison welcomes the opportunity to put our extensive knowledge and experience in products liability law to work for you. If you would like a free consultation about your potential products liability case, contact our Austin injury attorney online or give us a call at (512) 474-8346.
Did You Know: In 2010, the FDA warned that a counterfeit version of Alli was being sold online, and was potentially harmful to consumers.
The Law Offices of Aaron Allison – Austin Personal Injury Attorney
Source: http://money.cnn.com/2014/03/27/news/companies/glaxosmithkline-alli-recall/
